Gelonghui March 15 | Zhongke Biotech (01237.HK) announced that the company will approve the annual results announcements of the company and its subsidiaries for the year ended December 31, 2023 for publication at the board meeting to be held on March 28, 2024, and is expected to implement the dividend payment proposal (if any) and handle other matters.
中科生物(01237.HK)3月28日举行董事会会议批准年度业绩
Zhongke Biotech (01237.HK) held a board meeting on March 28 to approve annual results
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.